A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials
Shelley Potter(At Bristol), Maggie Banys-Paluchowski, Michael Jiang(University of Bristol), Dominik Hlauschek(Austrian Breast & Colorectal Cancer Study Group), J Federmann(Austrian Breast & Colorectal Cancer Study Group), Hiroji Iwata(Aichi Cancer Center), Jean L. Wright(University of North Carolina at Chapel Hill), Nicholas Zdenkowski(Lake Macquarie Private Hospital), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Sofía Aragón(Acıbadem University), Saika Amreen(South Essex Partnership University Foundation NHS Trust), Stuart McIntosh(Queen's University Belfast), Han‐Byoel Lee(Seoul National University Hospital), M. Algara(Hospital Del Mar), Jana de Boniface(Karolinska Institutet), Hiroko Bando(University of Tsukuba), Cynthia Aristei(University of Perugia), Akif Enes Arıkan(University of Perugia), Selvamani Backianathan(University of Tsukuba), R Garcés García, Gustavo Werutsky(European Organisation for Research and Treatment of Cancer), Farah Asif(University of Manchester), Sanjoy Chatterjee(Tata Medical Center), Karla A. Sepulveda(Baylor College of Medicine), Andrew J. Spillane(Melanoma Institute Australia), Fiorita Poulakaki, Rosina Ahmed(Tata Medical Center), Marianne Aznar, Emmanouil Aligizakis(Hospital Universitário Evangélico de Curitiba), Gaurav Agarwal, Cinta Albacar, Nikolay Amirov, Katherine Cowan, Kerry Avery, Philip Poortmans, Roxolyana Abdah-Bortnyak, Mairead MacKenzie, Anne Meyn, Peter Dubsky, Sandra Finestone, Orit Kaidar-Person, Andrea L Richardson, María Belén Ancao, Khaled Abdelwahab, Philipp Wittmann, Stefan Aebi, Nick Abbott, David Dodwell, Alastair M Thompson, Puteri Abdul Haris(University of Lucerne)
UCL Discovery (University College London)
January 1, 2025
Cited by 0
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k